YS Biopharma Announces Changes to its Board Committees

Rhea-AI Summary

YS Biopharma Co., Ltd. (NASDAQ: YS) announced the appointment of Ms. Rui Yu as the new Chairperson of its Audit Committee, as a member of its Compensation Committee, and as a member of the Nominating and Corporate Governance Committee. Ms. Yu brings extensive experience in the healthcare and finance sectors, having previously held positions at Oceanpine Capital, China Renaissance Group, and Gerson Lehman Group. Her educational background includes degrees from Guangdong Pharmaceutical University, the University of Missouri School of Medicine, and the University of Chicago Booth School of Business.

GAITHERSBURG, Md., Jan. 8, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the Company's Board of Directors (the "Board") has approved Ms. Rui Yu as the new Chairperson of its Audit Committee, as a member of its Compensation Committee, and as a member of the Nominating and Corporate Governance Committee on January 7, 2024 (Beijing Time), with immediate effect. Ms. Yu currently serves as a partner at Oceanpine Capital, a position she has held since 2021. Prior to that, she served as a managing director at China Renaissance Group and vice president and head of China healthcare research at Gerson Lehman Group. Ms. Yu received her Bachelor of Science degree from Guangdong Pharmaceutical University, her Master of Science degree from the University of Missouri School of Medicine, and her MBA from the University of Chicago Booth School of Business with concentrations in finance, accounting and entrepreneurship.

Accordingly, the membership of each Board Committee will be as follows:

Audit Committee

Rui Yu (Chairperson), Viren Mehta, and Shaojing Tong

Compensation Committee

Viren Mehta (Chairperson), Ajit Shetty, Shaojing Tong, and Rui Yu

Nominating and Corporate Governance Committee

Ajit Shetty (Chairperson), Viren Mehta, Rui Yu, and Yi Zhang

About YS Biopharma

YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA® immunomodulating technology platform and a series of preventive and therapeutic biologics with a potential for improved Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles vaccines. YS Biopharma operates in China, the United States, Singapore and the Philippines, and is led by a management team that combines rich local expertise and global experience in the bio-pharmaceutical industry. For more information, please visit investor.ysbiopharm.com.

Investor Relations Contact
Robin Yang
Partner, ICR, LLC
Tel: +1 (212) 537-4035
Email: YSBiopharma.IR@icrinc.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ys-biopharma-announces-changes-to-its-board-committees-302028447.html

SOURCE YS Biopharma Co., Ltd.

FAQ

Who is the new Chairperson of YS Biopharma's Audit Committee?

Ms. Rui Yu has been appointed as the new Chairperson of YS Biopharma's Audit Committee.

What are the committees that Ms. Rui Yu has been appointed to?

Ms. Rui Yu has been appointed as a member of YS Biopharma's Compensation Committee and the Nominating and Corporate Governance Committee in addition to being the new Chairperson of the Audit Committee.

What is Ms. Rui Yu's educational background?

Ms. Rui Yu holds a Bachelor of Science degree from Guangdong Pharmaceutical University, a Master of Science degree from the University of Missouri School of Medicine, and an MBA from the University of Chicago Booth School of Business.

Where has Ms. Rui Yu previously worked?

Ms. Rui Yu has previously held positions at Oceanpine Capital, China Renaissance Group, and Gerson Lehman Group.

What is the ticker symbol for YS Biopharma?

The ticker symbol for YS Biopharma is YS.